Muthoot Microfin: Intimation with respect to the CareEdge Global rating
Muthoot Microfin (MUTHOOTMF) filed a disclosure titled "Intimation with respect to the CareEdge Global rating". The company is valued at about ₹2,724 crore.
What happened
Muthoot Microfin (MUTHOOTMF) filed a disclosure with the exchanges on 24 October 2026 at 01:12 PM titled "Intimation with respect to the CareEdge Global rating".
Company snapshot
Muthoot Microfin is a small-cap company, with a market value of about ₹2,724 crore.
The stock last traded at ₹159.8, against a 52-week range of ₹141.2–₹262.8 (39.2% below the high).
Before this filing the shares had moved −15.2% over the month and −36.1% over three months. Average daily turnover over the last 20 sessions was about ₹2.96 crore.
Promoters held 55.47% at the end of Q1 FY27. Foreign institutions owned 23.12% and domestic institutions 3.38%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 559 | 6.2 | 0.37 |
| Q2 FY26 | 576 | 30.5 | 1.82 |
| Q3 FY26 | 603 | 62.4 | 3.73 |
| Q4 FY26 | 632 | 71.1 | 4.24 |
| Q1 FY27 | 669 | 81.3 | 4.85 |
What history shows
This is not the company's first credit rating disclosure: BCEIE has 3 earlier filings of this kind on record since May 2026.
After those filings, the stock gained 0.9% on average the next trading day and was up 13.1% on average after five days (2 filings with price data).
Market-wide, 1,329 credit rating filings with an impact score of 50 or more saw an average next-day move of +0.1%, with 47% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 9 Jun 2026 | Credit rating | −1.5% | +11.8% |
| 9 Jun 2026 | Credit rating | +3.3% | +14.4% |
What to watch
- Whether other agencies take a similar view on the company's credit.
- 5 November 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.